How Iran Nuclear Deal May Impact US Medicine Exports

Law360, New York (December 11, 2013, 4:28 PM EST) -- The Nov. 23, 2013, announcement that the P5+1 countries — the United States, Russia, China, England and France plus Germany — and Iran reached “a set of initial understandings” on limiting and rolling back Iran’s nuclear program did not have immediately obvious implications for U.S. manufacturers of medicine and medical devices. Indeed, the White House’s fact sheet on the deal asserted that transactions related to Iran’s purchase of food, agricultural commodities, medicine and medical devices “have been explicitly exempted from sanctions by Congress.” That may be...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.